Research Projects
-
Liya Ding, PhD,
Dana Farber Cancer Institute
Early Career Investigator GrantTargeting Therapeutic Resistance to PARP Inhibition in Ovarian Cancer
-
Sandra Cascio, PhD,
Magee-Womens Research Institute
Early Career Investigator GrantEGFL6 as a New Regulator of Myeloid Cell Expansion and Function in HGSOC
-
Martin Cannon, PhD,
University of Arkansas for Medical Sciences
Collaborative Research Development GrantUnderstanding and Targeting Myeloid Populations in Ovarian Cancer
-
Ivan Ahel, PhD,
University of Oxford
Collaborative Research Development GrantExploiting PARP-Modulating Enzymes in Ovarian Cancer Therapy
-
Wei Zhou, PhD,
The Wistar Institute
Mentored Investigator GrantTargeting the mevalonate pathway in ARID1A-mutated ovarian cancer
-
Xueyang Yu, PhD,
Massachusetts Institute of Technology
Mentored Investigator GrantMacrophage Control of the Microenvironment Drives HGSOC Progression
-
Nidhi Sahni, PhD,
MD Anderson Cancer Center
Early Career Investigator GrantSystems Approach for PARP-based Novel Combination Therapy in Ovarian Cancer
-
David Chapel, MD,
Brigham and Women’s Hospital
Mentored Investigator GrantThe Migratory Precursor and Serous Carcinogenesis
-
Yilun Deng, PhD,
University of Texas Health Science Center at San Antonio
Mentored Investigator GrantCD122-Selective IL-2 Complexes as Novel Ovarian Cancer Therapy
-
James Duncan, PhD,
Fox Chase Cancer Center
Early Career Investigator GrantExploring PROTAC-Mediated Degradation of BRD4 in Ovarian Cancer
-
Mark Eckert, PhD,
University of Chicago
Early Career Investigator GrantThe Fate and Function of Adipocytes in Ovarian Cancer Metastasis
-
Sudipto Ganguly, PhD,
Johns Hopkins University
Early Career Investigator GrantCharacterizing a Novel Checkpoint Axis in High-Grade Serous Ovarian Cancer